Stone, V.M.; Ringqvist, E.E.; Larsson, P.G.; Domsgen, E.; Holmlund, U.; Sverremark-Ekström, E.; Flodström-Tullberg, M.
Inhibition of Type III Interferon Expression in Intestinal Epithelial Cells—A Strategy Used by Coxsackie B Virus to Evade the Host’s Innate Immune Response at the Primary Site of Infection? Microorganisms 2021, 9, 105.
https://doi.org/10.3390/microorganisms9010105
AMA Style
Stone VM, Ringqvist EE, Larsson PG, Domsgen E, Holmlund U, Sverremark-Ekström E, Flodström-Tullberg M.
Inhibition of Type III Interferon Expression in Intestinal Epithelial Cells—A Strategy Used by Coxsackie B Virus to Evade the Host’s Innate Immune Response at the Primary Site of Infection? Microorganisms. 2021; 9(1):105.
https://doi.org/10.3390/microorganisms9010105
Chicago/Turabian Style
Stone, Virginia M., Emma E. Ringqvist, Pär G. Larsson, Erna Domsgen, Ulrika Holmlund, Eva Sverremark-Ekström, and Malin Flodström-Tullberg.
2021. "Inhibition of Type III Interferon Expression in Intestinal Epithelial Cells—A Strategy Used by Coxsackie B Virus to Evade the Host’s Innate Immune Response at the Primary Site of Infection?" Microorganisms 9, no. 1: 105.
https://doi.org/10.3390/microorganisms9010105
APA Style
Stone, V. M., Ringqvist, E. E., Larsson, P. G., Domsgen, E., Holmlund, U., Sverremark-Ekström, E., & Flodström-Tullberg, M.
(2021). Inhibition of Type III Interferon Expression in Intestinal Epithelial Cells—A Strategy Used by Coxsackie B Virus to Evade the Host’s Innate Immune Response at the Primary Site of Infection? Microorganisms, 9(1), 105.
https://doi.org/10.3390/microorganisms9010105